Steve Williamson
Impact in
-
- Medication Adherence and Compliance
-
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmaceutical studies and practices 2
- Childhood Cancer Survivors' Quality of Life 1
- Surgery 2
- Co-authors
- Adam Todd (2 shared papers)Andy Husband (2 shared papers)Wasim Baqir (1 shared paper)Jon Allen (1 shared paper)Lee Tripcony (1 shared paper)Charles D. Voigt (1 shared paper)Ludwik K. Branski (1 shared paper)Graeme Dickie (1 shared paper)
- Journals
- International Journal of Clinical Pharmacy (2 papers)Acta Oncologica (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Clinical Journal of Sport Medicine (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Steve Williamson
11 papers receiving 79 citations
Peers
Comparison fields: 5 of 47
- Family Practice 9
- Geriatrics and Gerontology 13
- Otorhinolaryngology 8
- Rehabilitation 6
- Issues, ethics and legal aspects 1
Countries citing papers authored by Steve Williamson
This map shows the geographic impact of Steve Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Williamson more than expected).
Fields of papers citing papers by Steve Williamson
This network shows the impact of papers produced by Steve Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Williamson. The network helps show where Steve Williamson may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Williamson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 26 | |
| 2 | 2002 | 13 | |
| 3 | 1997 | 11 | |
| 4 | 2006 | 9 | |
| 5 | 2018 | 9 | |
| 6 | 1998 | 6 | |
| 7 | 2014 | 5 | |
| 8 | 2025 | 2 | |
| 9 | 2024 | 1 | |
| 10 | FMEA: a new approach to manage high risk medicines | 2009 | 1 |
| 11 | Be Clear on Cancer: Pharmacy students' views of communicating with cancer patients | 2013 | 1 |
| 12 | Guidelines for the Management of Extravasation | 2014 | 0 |
About Steve Williamson
Steve Williamson is a scholar working on Pediatrics, Perinatology and Child Health, Surgery, General Health Professions, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 84 indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (2 papers), Pharmaceutical studies and practices (2 papers), Health Policy Implementation Science (1 paper), Head and Neck Cancer Studies (1 paper), Advanced Radiotherapy Techniques (1 paper), Safe Handling of Antineoplastic Drugs (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper) and Suicide and Self-Harm Studies (1 paper). The work is most often cited by research in Family Practice (9 citations), Geriatrics and Gerontology (13 citations), Otorhinolaryngology (8 citations), Rehabilitation (6 citations) and Issues, ethics and legal aspects (1 citation). Steve Williamson has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Adam Todd, Andy Husband, Wasim Baqir, Jon Allen, Lee Tripcony, Charles D. Voigt, Ludwik K. Branski, Graeme Dickie, Richard J. Kagan and Chris Wratten. Their work appears in journals such as International Journal of Clinical Pharmacy, Acta Oncologica, Clinical Pharmacology & Therapeutics, Clinical Journal of Sport Medicine and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.